Risk factors for alloimmunisation in the general patient population
| dc.contributor.author | Eccles, S. | |
| dc.contributor.author | Crispin, P. | |
| dc.contributor.author | Vanniasinkam, T. | |
| dc.date.accessioned | 2015-06-22T03:47:10Z | |
| dc.date.available | 2015-06-22T03:47:10Z | |
| dc.date.issued | 2015-02 | |
| dc.date.updated | 2015-12-10T10:35:40Z | |
| dc.description.abstract | For hospitals providing services to regional populations, difficulties are associated with transferred patients with poorly communicated medical history and a risk of alloimmunisation. Identification of patients at risk would assist in treatment planning. A retrospective study of alloimmunised patients was undertaken, comparing the demographics and diagnoses of this population with a control patient population. A preponderance of diagnoses of Sepsis, Haematological Malignancy, GIT Bleeds and Renal Failure was demonstrated in the alloimmunised population. Consistent with prior studies, RhD negative patients and female patients were over-represented in the study group, which was also on average significantly older. | |
| dc.identifier.issn | 1473-0502 | en_AU |
| dc.identifier.uri | http://hdl.handle.net/1885/14045 | |
| dc.provenance | http://www.sherpa.ac.uk/romeo/issn/1473-0502/..."Author's post-print on open access repository after an embargo period of between 12 months and 48 months" from SHERPA/RoMEO site (as at 24/06/15) | |
| dc.publisher | Elsevier | |
| dc.relation.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.rights | © 2014 Elsevier | |
| dc.rights.license | Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International | |
| dc.source | Transfusion and Apheresis Science | |
| dc.subject | alloimmunisation | |
| dc.subject | red cell antibody | |
| dc.subject | transfusion | |
| dc.title | Risk factors for alloimmunisation in the general patient population | |
| dc.type | Journal article | |
| dcterms.accessRights | Open Access | |
| dcterms.dateAccepted | 2014-12-15 | |
| local.bibliographicCitation.issue | 1 | en_AU |
| local.bibliographicCitation.lastpage | 64 | en_AU |
| local.bibliographicCitation.startpage | 60 | en_AU |
| local.contributor.affiliation | Crispin, P., The Australian National University | en_AU |
| local.contributor.authoruid | a227103 | en_AU |
| local.identifier.absfor | 119999 - Medical and Health Sciences not elsewhere classified | |
| local.identifier.ariespublication | a383154xPUB1335 | |
| local.identifier.citationvolume | 52 | en_AU |
| local.identifier.doi | 10.1016/j.transci.2014.12.008 | en_AU |
| local.identifier.scopusID | 2-s2.0-84926136810 | |
| local.publisher.url | http://www.elsevier.com/ | en_AU |
| local.type.status | Accepted Version | en_AU |